ETCEMBLY
Etcembly is building the world’s largest machine learning database and unmatched immunology expertise to deliver the safest and most powerful TCR immunotherapies through rapid computer-assisted engineering.
ETCEMBLY
Industry:
Biotechnology Machine Learning
Founded:
2020-01-01
Address:
Hanwell, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.etcembly.com
Total Employee:
11+
Status:
Active
Similar Organizations
Camelot Biomedical Systems
Camelot Biomedical Systems is a consulting firm that expertise in machine learning, artificial intelligence and blockchain platforms.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Etcembly Appoints Scott Cuthill as Chief Business Officer |
Official Site Inspections
http://www.etcembly.com Semrush global rank: 7.4 M Semrush visits lastest month: 510
- Host name: server-3-167-56-72.iad61.r.cloudfront.net
- IP address: 3.167.56.72
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Etcembly"
Etcembly - Crunchbase Company Profile & Funding
Organization. Etcembly . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Etcembly is building the world’s largest machine learning …See details»
Etcembly | Engineering Next-Generation Biologics with AI
From Code to Cure: Etcembly combines cutting-edge artificial intelligence and bioengineering to accelerate therapeutic innovation and design next-generation immunotherapies. Learn how …See details»
Etcembly Company Profile 2024: Valuation, Funding
Etcembly was founded in 2019. Where is Etcembly headquartered? Etcembly is headquartered in Didcot, United Kingdom. What is the size of Etcembly? …See details»
Etcembly Ltd - LinkedIn
Etcembly Ltd | 3,119 followers on LinkedIn. TCRs by intelligent design | Etcembly’s vision is to decode immune repertoires for health and disease. The TCR repertoire holds the answers to ...See details»
Etcembly - Overview, News & Similar companies | ZoomInfo.com
Apr 4, 2023 Etcembly is a UK biotech company harnessing the power of the adaptive immune system to transform the precision, scale and speed of clinical develop ment of …See details»
Etcembly - VentureRadar
Etcembly is the synthesis of bridging machine learning and traditional drug discovery. Our mission is to build an immune pattern recognition system EMLy (Etcembly Machine Learning). We are …See details»
ETCEMBLY LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ETCEMBLY LTD of DIDCOT. Get the latest business insights from Dun & Bradstreet. ETCEMBLY LTD. …See details»
Etcembly - Company Profile - Tracxn
Etcembly - AI-assisted platform for T-cell receptor target discovery and development. Raised a total funding of $12.6M over 4 rounds from 7 investors. Valued at $29.9M. Etcembly has 281 …See details»
Oxford-based machine learning start-up Etcembly ... - Etcembly …
Feb 7, 2022 Etcembly is a privately owned, Oxfordshire-based company. Its mission is to decode immune repertoires in health and disease by building a pioneering machine learning …See details»
Etcembly - Products, Competitors, Financials, Employees, …
Etcembly is a company focused on the intersection of immunology and machine learning, operating within the healthcare and technology sectors. The company's main service is the …See details»
Michelle Teng - Chief Executive Officer @ Etcembly - Crunchbase
Michelle is a supporter of rare diseases and a science entrepreneur. She is the founder and CEO of the technology startup Etcembly, situated in Oxford. Following her daughter's H-ABC …See details»
Etcembly - Updates, News, Events, Signals & Triggers - Crunchbase
Etcembly is building the worlds largest machine learning database and unmatched immunology.See details»
Etcembly establishes new lab & office space at ... - Etcembly Feb2022
Feb 7, 2022 Etcembly is a privately owned, Oxfordshire-based company. Its mission is to decode immune repertoires in health and disease by building a pioneering machine learning …See details»
Etcembly - RC Harwell
Etcembly, based in the Atlas Centre at Harwell Campus is a Generative AI (artificial intelligence) T Cell Receptor (TCR) discovery engineering company. T cells are immune cells in the blood …See details»
Etcembly | Contact
Etcembly Limited, Atlas Building Fermi Avenue, Harwell Campus, Didcot, Oxfordshire, England, OX11 0QX. top of page. Long Term Survivor Study. Our Goal. ETCh Study. Who can …See details»
Etcembly makes T Cell Receptor breakthrough - Harwell Campus
Dec 21, 2022 Etcembly’s CEO and co-founder Michelle Teng said, “Finding TCRs without undesirable off target effects is a big pain point in immunotherapy. The time-consuming …See details»
Etcembly - Contacts, Employees, Board Members, Advisors & Alumni
Etcembly has 2 current employee profiles, including Chief Business Officer Scott Cuthill. Scott Cuthill Chief Business Officer Michelle Teng Chief Executive OfficerSee details»
Etcembly have been picked by Oliver Sims of Octopus Ventures as …
Aug 22, 2024 Etcembly have been picked by Oliver Sims of Octopus Ventures as one of the top 13 techbio companies to watch. He says, "As the demand for personalised treatments grows …See details»
News and views from the Etcembly team - Etcembly Feb2022
From Code to Cure: Etcembly are Engineering Next-Generation Biologics with AI. We combine cutting-edge artificial intelligence and bioengineering to accelerate therapeutic innovation and …See details»
Etcembly | Long Term Survivor Study
At Etcembly, a crucial part of this mission is our focus on long-term cancer survivors – people whose immune systems have successfully fought the disease. Using our advanced AI-driven …See details»